10 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Q-FIX Knotless All-Suture Anchor, 1.8 mm, with one ULTRABRAID suture, blue; Q-FIX Knotless All-Suture Anchor, 1.8 mm, with one ULTRABRAID suture, co-braid-blue; Q-FIX Knotless All-Suture Anchor, 1.8 mm, with one MINITAPE suture, blue; Q-FIX Knotless All-Suture Anchor, 1.8 mm, with one MINITAPE suture, co-braid-blue

FDA 510(k)
FDA Class 2 ·Orthopedic

Sochi

FDA UDI
Altus Spine, LLC·00843210168562·Screw Offset, Open, 35mm

Coral

FDA UDI
Seaspine Orthopedics Corporation·10889981030285·Screw Offset - Open, 35mm

THE STRIPPER PGD

FDA 510(k)
FDA Class 2 ·Obstetrics/Gynecology

OPAL CHIRO, 20/20 P-DR

FDA 510(k)
FDA Class 2 ·Radiology

PROGRAMMING SOFTWARE

FDA Adverse Event
Malfunction ·CYBERONICS, INC.·Product code LYJ·August 18, 2011

AMS THERMATRX TMX-3000 OFFICE THERMOTHERAPY

FDA Adverse Event
Injury ·AMERICAN MEDICAL SYSTEMS (MN)·Product code MEQ·November 10, 2014

IN TOUCH ZU

FDA Adverse Event
Malfunction ·STRYKER MEDICAL-KALAMAZOO·Product code FNL·July 22, 2013

OmniDiagnost Eleva System codes 708028 708027

FDA Enforcement
Class II ·Terminated·Philips North America, LLC·March 25, 2020

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014